Member Info for spbhoy

And if it doesn't drop below 150p but rises to 200p, you either keep yourself heavily exposed or pay 200p per share to buy them back...and lose 50p per share. Here's hoping Jupiter do their investors a very large dis-service.

https://twitter.com/mylesmcnulty/status/1412709858550419456?s=21

Just heard that too, but unfortunately she then stated how poor these tests were (Innova). She either knows the plan and thinks they will continue with Innova or she's on the outside and is unaware of what others can provide (ODX, AVCT etc). Same as when she discussed the current trial with 40k close contacts who are testing daily rather than isolating...essentialy getting a day pass through LFT.

Any intraday RNS with any positive news of importance will take us further than 200p.

If you click the little "download" button, it then gives you more specific detail about the S & S etc.

@faramog, I'm not interested in telegram ra ra style comments, but I am able to read and digest the news the same as you can. What I choose not to do is to proceed to trash the company any further by re-highlighting the many negatives in the results. I already understood what they were and see no need to reiterate them through the day.

What's done is done.

The reason I stopped back from this BB was similar to yours I suppose. I have no interest in a **** measuring contest as that has no bearing on anything. Frankly, I have always believed that it's bad news and bordering on stupidity to publicly trash any company in which you are invested, if you indeed remain invested. Obviously you believe otherwise....as you are entitled to do so.

Well done to your team last night, unfortunately mine left stage left last week.

I guess you no longer hold BMN shares Faramog. Why didn't you just start a new thread "RNS Thoughts - Just the negatives"

@greedo76 try this
https://twitter.com/tom_the_bomb__/status/1408038244567109638

Beat me to it Richob.

@dsaf, Friday close was 219.44p....not 232

@MR.Spacetomato...they sold around £30m of their holding in Burford in the same period, hence why i suspect it's simply housekeeping on their part.

It's nothing to do solely with AVCT as they also sold a huge chunk of Burford (see their RNS 7th June). Housekeeping seems the most likely scenario....especially at 100% profit on their AVCT sales.

They are at just under 50% of the daily average already...although they have just dropped from $11.95 to $11.75 in the

Decent pre-market and now live market volume on LBPS in USA

It's taken all of 1.5 hours but Waynesmith finally crosses the line in first place.

And while it was hard to buy shares it was impossible to open any new spread bet positions...closing bets only. Tells it's own story

@pigster, that's correct, it hasn't changed. However when you combine this with the statement about manufacturers consent, it does make some sense. With Avacta, it's often a case of what has not been said than what is said.

It lists Mass Spec (test 43 on list) as "validated" in the paused or concluded section. It shows 11 out of 13 tests as validated in the validated list. Can it therefore be assumed that the Mass Spec test that has been validated is one of the two missing from the "validated list" because "Other technologies that have been validated will be added to the table once the manufacturer has consented to publication"

Search Google for Ridrodsky & Long and you will get a list the length of your arm of companies that they are starting to investigate. Tells it's own story really. https://www.google.com/search?client=safari&rls=en&q=Rigrodsky+%26+Long+comments&ie=UTF-8&oe=UTF-8

@lazypunter, could you perhaps explain what you meant by this statement back in June and also similar statements though August: "However, if you are researched , patient and able to afford the luxury of giving Avacta the time it needs, the prize money will be secured ..it will not do it in days ,weeks or months perhaps , as the race is a long one but if what I have read, seen on video and believe is true, Avacta will cut through the field and deliver the results we hope for .LP"

I suspect that you are no longer invested as you claim to be, which would be quite a shame when Avacta cuts through the field and delivers...